688163 賽倫生物
按盤價 
40.660 +3.350 (+8.979%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.193 | 4.691 | 4.061 | 3.513 | 8.610 |
| 總資產報酬率 ROA (%) | 3.045 | 4.548 | 3.940 | 3.379 | 8.181 |
| 投入資產回報率 ROIC (%) | 3.159 | 4.651 | 4.008 | 3.446 | 8.387 | 邊際利潤分析 |
| 銷售毛利率 (%) | 78.281 | 78.121 | 78.057 | 75.709 | 83.770 |
| 營業利潤率 (%) | 38.915 | 32.877 | 26.670 | 24.184 | 42.855 |
| 息稅前利潤/營業總收入 (%) | 38.410 | 32.041 | 25.084 | 22.672 | 40.964 |
| 淨利潤/營業總收入 (%) | 34.211 | 26.394 | 22.723 | 20.392 | 36.849 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 97.099 | 86.739 | 101.801 | 88.006 | 78.660 |
| 價值變動淨收益/利潤總額(%) | 14.552 | 16.486 | 10.223 | 22.756 | 21.667 |
| 營業外收支淨額/利潤總額(%) | -1.492 | -0.469 | -2.806 | -1.252 | -0.843 | 償債能力分析 |
| 流動比率 (X) | 16.079 | 24.715 | 46.700 | 37.979 | 37.104 |
| 速動比率 (X) | 15.350 | 23.549 | 44.495 | 36.188 | 35.075 |
| 資產負債率 (%) | 5.397 | 3.850 | 2.190 | 3.778 | 3.845 |
| 帶息債務/全部投入資本 (%) | 0.423 | 0.351 | 0.227 | 0.333 | 0.294 |
| 股東權益/帶息債務 (%) | 23,389.086 | 28,159.141 | 43,849.608 | 29,465.780 | 33,387.045 |
| 股東權益/負債合計 (%) | 1,752.809 | 2,497.391 | 4,465.353 | 2,547.012 | 2,500.496 |
| 利息保障倍數 (X) | 577.305 | -46.896 | -29.206 | -18.689 | -26.735 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 96.952 | 66.732 | 54.775 | 28.697 | 17.841 |
| 存貨周轉天數 (天) | 333.422 | 361.884 | 370.449 | 386.922 | 660.221 |
| 備註： | 即時報價更新時間為 28/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
